REGEN

Find an event near you to learn more about how Suneva Medical’s portfolio of regenerative aesthetic products can set your practice apart.

Upcoming events

Nashville

Tennesse

june 2, 2022

6 PM PST

The Westin Nashville

807 Clark place nashville, TN 37203

Plasma IQ and the suneva regenrative aesthetics portfolio

Kimber Arnold

LVN

Birmingham

Alabama

june 14, 2022

6 PM PST

Fleming’s Steakhouse & Wine Bar

103 Summit Blvd Birmingham, AL 35243

Plasma IQ and the suneva regenrative aesthetics portfolio

Brian Pilcher

PhD

Madison

Wisconsin

june 22, 2022

6 PM PST

EnoVino Wine Bar & Bistro

1 North Webster St Madison, WI 53703

Plasma IQ and the suneva regenrative aesthetics portfolio

Amie Neumaier

BSN RS CANS

Pittsburgh

Pennsylvania

june 23, 2022

6 PM PST

The Westin Pittsburgh

1000 Pen Ave Pittsburgh, PA 15222

Plasma IQ and the suneva regenrative aesthetics portfolio

Kimber Arnold

LVN

Oak Brook

Illinois

june 28, 2022

6 PM PST

Perry’s Steakhouse & Grille

Oakbrook Center Oak Brook, IL 60523

Plasma IQ and the suneva regenrative aesthetics portfolio

Brian Pilcher

PhD

Boston

Massachusetts

june 29, 2022

5 PM PST

Dell Frisco’s Double Eagle Steakhouse

250 Northern Ave, Suite 200 Boston, MA 02210

Plasma IQ and the suneva regenrative aesthetics portfolio

Pat Altavila

Suneva Medical CEO

Fargo

North Dakota

july 20, 2022

6 PM PST

Jasper Hotel

Rosewild Retaurant 215 Broadway N. Fargo, ND 58102

Plasma IQ and the suneva regenrative aesthetics portfolio

Rachna Kalhan

PharmD

Anchorage

Alaska

november 3, 2022

6 PM PST

Marriott Anchorage Downtown

820 W 7th Ave. Anchorage, AK 99105

Plasma IQ and the suneva regenrative aesthetics portfolio

Brian Pilcher

PhD

Important Safety Information

Bellafill®
Bellafill® is indicated for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years. Patients who have had a positive reaction to the Bellafill® Skin Test, have a history of severe allergies, have known bovine collagen allergies, are allergic to lidocaine, have bleeding disorders or are prone to thick scar formation and/or excessive scarring should not receive Bellafill®. The safety of Bellafill® for use during pregnancy, breastfeeding, or in patients under 21 has not been established. You may experience temporary swelling, redness, pain, bruising, lumps/bumps, itching, and discoloration at the treatment site. These side effects are usually transient and typically resolve within 1–7 days. You may experience lumps/bumps/papules that may occur more than one month after injection and that may persist. Less common side effects include rash and itching more than 48 hours after treatment, persistent swelling or redness, lumps/bumps, acne, and increased sensitivity at treatment sites. Infrequently, granulomas may occur and may be treated by your licensed physician provider. Be sure to call your licensed provider immediately if you notice any unusual skin reactions around the treatment area. Based on the 5-year Post-Approval Study on nasolabial folds with 1,008 patients, long-term safety of Bellafill® for up to 5 years has been established.

PUREGRAFT
This product is certified as a medical device in the European Union under the Medical Device Directive 93/42/EEC by SGS CE0120, exclusively for the indication of autologous fat transfer. Other non-medical uses ascribed to this device such as aesthetic body contouring are not within the scope of CE certification, and users should be aware product performance and/or safety has not been evaluated by SGS for those purposes.

Suneva Medical HD PRP
REGULATORY STATUS: FDA-cleared 510(k) Class II medical device. Healeon HD PRP is designed to be used for the safe and rapid preparation of autologous platelet-rich-plasma (PRP) from a small sample of peripheral blood at the patient point of care. The PRP is mixed with autograft and/orallograft bone prior to application to a bony defect for improving handling characteristics. 510(k) number: BK170136

Silhouette Instalift
Silhouette lnstaLift® is indicated for use in mid-face suspension surgery to temporarily fixate the cheek sub-dermis in an elevated position.

IMPORTANT SAFETY CONSIDERATIONS
The Silhouette InstaLift device should not be used in patients with any known allergy or foreign body sensitivities to plastic/ biomaterial or in situations where internal fixation is otherwise contraindicated, (e.g. infection.) The device should also not be used in patients appearing to have very thin soft tissue of the face in which the implant may be visible or palpable.

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction, pain (which may be temporary or persistent in nature), swelling and edema, transient hematoma or bruising and transient rippling or dimple formation. For further safety or product information, please consult your physician.

For more safety information, please consult with your physician and the patient labeling that can be found by visiting our website www.bellafill.com.
Toll-free call (U.S. & Canada): 844-Bellafill (844-235-5234).
Local calls: 858-550-9999. International calls: ++ 858-550-9999.